Skip to content

Clinical trials

Completed Pulmonary Arterial Hypertension trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Status: Completed Country / region: Poland Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20062
20071
20084
20092
20102
20111
20122
20132
20141
20151
20173
20181
20193
20214
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Actelion10
United Therapeutics8
Bayer5
Merck Sharp & Dohme LLC2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA1
Altavant Sciences GmbH1
Centre of Postgraduate Medical Education1
Eli Lilly and Company1
GB002, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension33
Hypertension, Pulmonary10
Cardiovascular Diseases1
Connective Tissue Diseases1
Eisenmenger Complex1
Familial Primary Pulmonary Hypertension1
Hypertension1
Lung Diseases1
Respiratory Tract Diseases1
Vascular Diseases1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.